CarePartners of Connecticut Medical Necessity Guideline Updates
Updates to Medical Necessity Guidelines (MNG)
|
MNG Title |
Effective Date |
Summary |
|---|---|---|
|
Aug. 1, 2023 |
Prior authorization now required for Qalsoldy (HCPCS code J3490), approved by the FDA in April 2023 for the treatment of ALS in adults who have a mutation in the superoxide dismutase 1 (SOD1) gene. |
|
|
July 11, 2023 |
Prior authorization now required for Leqembi (HCPCS code J3490), approved by the FDA in July 2023 for the treatment of Alzheimer's disease. |
|
|
Aug. 1, 2023 |
Prior authorization now required for Syfovre (HCPCS code C9151), approved by the FDA in February 2023 for treatment of geographic atrophy (GA) secondary to age-related macular degeneration. |